Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04996017
Title Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso) (AtezoMeso)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Gruppo Oncologico Italiano di Ricerca Clinica
Indications

malignant pleural mesothelioma

Therapies

Atezolizumab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.